InvestorsHub Logo
Followers 28
Posts 4765
Boards Moderated 3
Alias Born 04/05/2017

Re: None

Wednesday, 03/27/2024 1:25:41 PM

Wednesday, March 27, 2024 1:25:41 PM

Post# of 33238
Endonovo needs to fire this PR firm.

They are releasing a PR that was initially out in 2016 or sometime close to that year. 😄
Certainly is not applicable to now.

"has plans to apply for orphan drug designation for its next-generation, off-the-shelf treatment of Graft-Versus-Host (GvHD) disease, using enhanced stem cells from the human umbilical cord. If Endonovo receives FDA approval to market its product, the company could easily reach a billion-dollar valuation."


https://blog.doctorsbusinessnetwork.com/biotech-companies-stock-in-your-portfolio/?utm_source=dlvr.it&utm_medium=linkedin
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENDV News